↓ Skip to main content

Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years

Overview of attention for article published in Lipids in Health and Disease, January 2014
Altmetric Badge

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years
Published in
Lipids in Health and Disease, January 2014
DOI 10.1186/1476-511x-13-13
Pubmed ID
Authors

Christian Constance, Ori Ben-Yehuda, Nanette K Wenger, Franklin Zieve, Jianxin Lin, Mary E Hanson, Robert S Lowe, Andrew M Tershakovec

Abstract

Few clinical studies have focused on the efficacy of lipid-lowering therapies in patients ≥65 years.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
Unknown 54 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 13%
Researcher 7 13%
Student > Postgraduate 6 11%
Student > Master 6 11%
Other 4 7%
Other 9 16%
Unknown 16 29%
Readers by discipline Count As %
Medicine and Dentistry 15 27%
Pharmacology, Toxicology and Pharmaceutical Science 8 15%
Biochemistry, Genetics and Molecular Biology 3 5%
Nursing and Health Professions 3 5%
Agricultural and Biological Sciences 2 4%
Other 7 13%
Unknown 17 31%